Amgen Inc ESMO Call Transcript

Oct 24, 2023 / 12:00PM GMT

Hello. My name is Sarah, and I will be your conference facilitator today for Amgen's conference call following the 2023 European Society for Medical Oncology Congress. (Operator Instructions) I would now like to introduce Mr. David Reese, Executive Vice President of Research and Development. Mr. Reese, you may now begin.

David M. Reese - Amgen Inc. - EVP of Research & Development

Thanks, Sarah, and good morning and good afternoon, everyone, depending on where you're joining us from. We're very happy today to give an update on our oncology pipeline after the ESMO meeting, where we had some major data presentations. We have a lot of materials, so we're going to jump right in, in just a moment.

I would note that all of the slides that we're presenting today will be posted on our website immediately following the call.

On the next slide, is our standard safe harbor statement. And if we move to the next slide, you'll see the agenda today. I'll give an introduction to our strategy. Just as a reminder, very briefly, I do want to say a few words

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
4.6 out of 5 Trustpilot